Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Principia Biopharma patents proteasome subunit beta type-8 and/or beta type-9 inhibitors

June 7, 2019

Senju Pharmaceutical synthesizes new PAC1 and/or VPAC1 and/or VPAC2 receptor ligands

June 6, 2019

CCR5 mutation leads to increased mortality

June 4, 2019

FOX-115 improves endurance of motor performances in aged mice

May 20, 2019

Vasopressin V2 receptor antagonists disclosed by Toa Eiyo

May 17, 2019

Boehringer Ingelheim identifies new Bruton tyrosine kinase inhibitors

May 3, 2019

Bristol-Myers Squibb synthesizes new galectin 3 inhibitors

April 30, 2019

Nihon Pharmaceutical and Niigata University present liver integrated bone marrow-derived stem cells

April 18, 2019

Galapagos initiates first-in-human trial of GLPG-3121

April 11, 2019

Aduro BioTech discovers cyclic GMP-AMP synthase inhibitors

April 9, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.